Yong Dai
Corporate Officer/Principal chez PREVAIL THERAPEUTICS INC.
Provenance du réseau au premier degré de Yong Dai
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
21
| Public Company | Biotechnology | 21 |
| Subsidiary | Biotechnology | 11 | |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Frontera Therapeutics (HK) Ltd.
 Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company was founded by Yong Dai and Yong Dai has been the CEO since incorporation.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Yong Dai via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Human Resources Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ACUMEN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Chairman Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Public Communications Contact Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member | |
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Graviton Bioscience Corp. develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases. The company is based in New York, NY. The company was founded by Samuel D. Waksal. Samuel D. Waksal has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Spearhead Investments (Bio) Ltd. | Chairman | ||
Aliment Capital Llc
 Aliment Capital Llc Investment ManagersFinance Aliment Capital LLC (Aliment Capital) is a venture capital subsidiary of Pontifax Management Co. Ltd. founded in 2014 by Philip Robert Erlanger and Ben Belldegrun. The firm is headquartered in California, United States. | Investment Managers | Consultant / Advisor | |
| Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal | ||
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member | |
| Pontifax (Cayman) III LP | Investment Managers | Director/Board Member | |
| Pontifax (Israel) III LP | Investment Managers | Director/Board Member | |
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member | |
N T B Pharma Ltd.
 N T B Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services N T B Pharma Ltd. provides scientific and technical research development services. The private company is based in Herzliya, Israel. | Miscellaneous Commercial Services | Director/Board Member | |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Biotechnology | Director/Board Member | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Public Communications Contact | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| CADRENAL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
DiNAQOR AG
 DiNAQOR AG BiotechnologyHealth Technology DiNAQOR AG is a Swiss genetic medicine platform company that focuses on developing innovative solutions for patients with severe, inherited forms of heart disease. The private company is based in Pfäffikon, Switzerland, and has additional presence in Massachusetts and other locations. The company's lead preclinical program, DINA-001, is aimed at treating mybpc3-linked cardiomyopathy. Founded in 2019, the CEO of DiNAQOR is Johannes Holzmeister. | Biotechnology | Director/Board Member | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Hershey Medical Center | College/University | Corporate Officer/Principal | |
| Philadelphia College of Osteopathic Medicine | College/University | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 38 |
| Israël | 9 |
| Suisse | 3 |
| Pays-Bas | 2 |
| Suède | 2 |
Sectorielle
| Health Technology | 35 |
| Finance | 7 |
| Consumer Services | 5 |
| Commercial Services | 4 |
| Government | 2 |
Opérationnelle
| Director/Board Member | 223 |
| Corporate Officer/Principal | 90 |
| Independent Dir/Board Member | 76 |
| Chairman | 33 |
| Chief Tech/Sci/R&D Officer | 28 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Peter Thompson | 39 |
| Ran Nussbaum | 38 |
| Francois Nader | 28 |
| Ferdinand Verdonck | 25 |
| Franz Hefti | 23 |
| Joseph Feczko | 23 |
| Tim Adams | 17 |
| Jörn Aldag | 15 |
| Madhavan Balachandran | 15 |
| William Carson | 14 |
| Don Soland | 14 |
| Jeremy Springhorn | 14 |
| Steven Zelenkofske | 13 |
| Rikard Ekberg | 11 |
